Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives

July 29, 2021

Bristol Myers Squibb patents diacylglycerol kinase alpha/zeta inhibitors

July 28, 2021

Dual GCGR and GLP-1 agonists patented by Merck & Co.

July 28, 2021

Medshine Discovery discovers ketohexokinase inhibitors

July 28, 2021

Jiangsu Simcere Pharmaceutical R&D describes TGF-beta receptor type-1 inhibitors

July 27, 2021

New DGAT-2 inhibitors discovered at LG Chem

July 27, 2021

Beijing Scitech-Mq Pharmaceuticals identifies new FGFR4 inhibitors

July 27, 2021

Japan Tobacco divulges new NLRP3 inflammasome inhibitors

July 27, 2021

New glucagon-like peptide 1 derivatives identified at Gan & Lee Pharmaceuticals

July 26, 2021

Multiple kinase inhibitors identified at Medshine Discovery

July 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...